title: A central role of heme oxygenase-1 in cardiovascular protection.
abstract: The intrinsic defense mechanisms of the body are critical in protecting tissues from injury in response to pathological stress. Heme oxygenase-1 (HO-1), a stress response protein, is induced in response to various pathological stimuli to serve a cytoprotective function. By degrading the oxidant heme and generating the antioxidant bilirubin and anti-inflammatory molecule carbon monoxide, HO-1 may protect cell from injury due to oxidative and pathological stress. Oxidative stress in the heart caused by ischemia and reperfusion leads to cardiomyocyte death and subsequent myocardial infarction. Vascular diseases including atherosclerosis, graft failure, and restenosis are all associated with reactive oxygen species-induced injury and inflammation. Given that cardiovascular disease is the leading cause of death worldwide, there is considerable interest in developing new strategies for preventing and treating cardiovascular disease. Since HO-1 is induced in the heart and blood vessels in response to various stresses, a role of HO-1 has been implicated in cardiovascular homeostasis. Numerous studies using pharmacological method or genetic approach have since demonstrated the cardiovascular protective function of HO-1. Importantly, a number of studies have associated human HO-1 gene promoter polymorphisms with risk for vascular diseases. Taken together, HO-1 has a great therapeutic potential for cardiovascular disease.
authors.affiliation: Institute of Cellular and System Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli, Taiwan.
authors.forename: Meng-Ling
authors.initials: ML
authors.lastname: Wu
authors.forename: Yen-Chun
authors.initials: YC
authors.lastname: Ho
authors.forename: Shaw-Fang
authors.initials: SF
authors.lastname: Yet
mesh_terms: D000818:Animals; D001158:Arteries / Q000201:enzymology / Q000293:injuries; D050197:Atherosclerosis / Q000201:enzymology / Q000473:pathology; D003331:Coronary Vessels / Q000201:enzymology / Q000473:pathology; D048909:Diabetes Complications; D015316:Genetic Therapy; D006083:Graft Occlusion, Vascular / Q000201:enzymology / Q000473:pathology; D006084:Graft Rejection / Q000201:enzymology / Q000473:pathology; D006331:Heart Diseases / Q000201:enzymology* / Q000209:etiology / Q000473:pathology / Q000628:therapy; D051547:Heme Oxygenase-1 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D000860:Hypoxia; D018895:Microsatellite Repeats; D009206:Myocardium / Q000201:enzymology / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000201:enzymology; D058226:Plaque, Atherosclerotic / Q000201:enzymology / Q000473:pathology; D013927:Thrombosis / Q000201:enzymology / Q000473:pathology
chemical_list: D051547:Heme Oxygenase-1